NASEM Health and Medicine Division’s Post

Our new publication summarizes a #MedPrepForum virtual workshop series from Fall 2023 discussing future opportunities for public-private partnerships to facilitate medical countermeasures delivery and uptake during a public health emergency. Read the proceedings here: https://ow.ly/ervA50QSfeq #PublicPrivatePartnerships #HealthEmergency

"Every move counts could save millions of lives—but why is it still missing from medical school curricula?" In our latest @BJSM_BMJ editorial, we explore how the #VANGUARD project is reshaping healthcare education to fight noncommunicable diseases. This change is long overdue. Read more here: https://lnkd.in/e4kYEc7W #HealthcareInnovation #MovementForMovement #GlobalHealth #NCDPrevention

I am happy to share our recent commentary in @BMJGlobalHealth on "Shaping the Future of Global Access to Health Products" lead by  Raffaella Ravinetto et al. Global access to quality health products is still a challenge. Our commentary delves into the persisting gaps and proposes crucial steps for improvement. Redesigning the pharmaceutical innovation ecosystem is vital. Coherence between market-driven approaches and public health needs is essential for equitable access. National health systems must prioritize transparent criteria for access to essential health products. Evidence-based decisions and health technology assessment can drive progress. Strengthening regulatory and supply systems is a must. A robust infrastructure ensures safe, effective, and timely access to health products globally. Financial health protection is integral to achieving universal health coverage. It's time to integrate it into the broader health agenda for sustained progress. Lessons from the past must guide our future actions. Let's view medical innovation and essential health products as common goods, not just commercial assets. #GlobalHealth #HealthProducts #PublicHealth #MedicalInnovation #AccessToMedicines

Fülöp Scheibler and colleagues recently published an article in BMJ EBM entitled “Patient-reported effects of hospital-wide implementation of shared decision-making at a university medical centre in Germany”. This article describes the implementation of SDM in a hospital. Despite the challenges of implementation, the authors were able to demonstrate the feasibility and effectiveness of implementing SDM. They also report significant improvements in patient involvement in treatment decisions following implementation. The study also has wider implications. To learn more, read the full article here.   https://lnkd.in/gUpNQX2x

Knowledge Share Current Awareness Report [This study discusses the importance of involving KUs (I.e. patient and public partners, healthcare providers and policy-makers) in developing Rapid Reviews, provides detailed steps on how and when to involve KUs, including patient and public involvement, and offers suggestions that research teams should consider to facilitate their involvement. Meaningful KUs involvement requires time, resources and advanced planning, given the condensed timelines of RRs]. #rapidreviews

The most difficult step in Choosing Wisely initiatives: de-implementation ... The last decade has shown that good intentions are not always followed by effective actions. Listing the therapeutic or diagnostic interventions that add no real value to the management of patients is 'easy', but convincing patients and physicians to get rid of them is the most difficult challenge... This paper makes some interesting proposals to pass this hurdle and decrease low value care, based on successive steps. https://lnkd.in/eNu5sJji

second medical opinion: a grey area Patients seeking a second opinion sought to gain more information or reassurance about their diagnosis or treatment. While many second opinions confirm the original diagnosis or treatment, discrepancies in opinions had a potential major impact on patient outcomes in up to 58% of cases. No studies reported on the cost effectiveness of patient initiated second opinions. More research is needed to understand the cost effectiveness of second opinions and identify patient groups most likely to benefit from second opinions. https://lnkd.in/d2m29wtw https://lnkd.in/dSPm_GJm

This piece of original research from Open Quality is an evaluation of the Practical Guide to Implementing patient-reported outcome measures (PROMs) in Gender-Affirming Care (PG-PROM-GAC). Read the article now to find out the conclusions from the assessment: https://bit.ly/3QyNwQ7 #QualityImprovement #ImprovementinHealthcare #GenderAffirmingCare

The field of #healthcare is dynamic, and as #environmental awareness continues to grow, patients are likely to become more attuned to the ecological implications of medical treatments. Proactively incorporating green informed consent prepares the healthcare system for future expectations and aligns with evolving societal values. Read more on the importance of harmonising green #informedconsent with autonomous clinical decision-making in our latest perspective article: https://lnkd.in/dQekBtqc Eva Cohen Wouter Hehenkamp @Cristine Richie

Our last publication, lead by Raffaella Ravinetto and colleagues from Europe, Africa, Asia and Latin America. Medical innovation and essential health products are critical public health tools and should be treated as common goods instead of private commercial assets. Coordinated progress is urgently needed in four domains: 1) redesigning the pharmaceutical innovation ecosystem and its policy environment to resolve the incoherence between market-driven approaches and public health needs; 2) applying evidence-based and transparent prioritisation criteria in the national health systems; 3) strengthening the regulatory and supply systems; and 4) promoting financial health protection as part of universal health coverage. To read more click below: